About
Technology
Issues
FAQ
Links
Official Page
A double‐blind, placebo‐controlled study to assess the mitochondria‐targeted antioxidant MitoQ as a disease‐modifying therapy in Parkinson's disease
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.